Raiffeisen Bank International AG Raises Stake in Ventas, Inc. $VTR

Raiffeisen Bank International AG lifted its stake in Ventas, Inc. (NYSE:VTRFree Report) by 4,071.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,470 shares of the real estate investment trust’s stock after buying an additional 10,219 shares during the quarter. Raiffeisen Bank International AG’s holdings in Ventas were worth $935,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of VTR. Dynamic Wealth Strategies LLC bought a new stake in shares of Ventas in the 1st quarter valued at about $25,000. Wiser Advisor Group LLC purchased a new stake in shares of Ventas during the 3rd quarter valued at $27,000. Silvant Capital Management LLC acquired a new position in Ventas during the 2nd quarter valued at about $28,000. Meeder Asset Management Inc. acquired a new position in shares of Ventas during the second quarter valued at about $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas during the fourth quarter valued at $30,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Stock Down 2.0%

VTR opened at $90.27 on Friday. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The stock has a fifty day moving average of $92.94 and a 200-day moving average of $87.82. The company has a market capitalization of $46.30 billion, a P/E ratio of 167.17, a P/E/G ratio of 3.52 and a beta of 0.70.

Ventas (NYSE:VTRGet Free Report) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.87 earnings per share. On average, equities analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Scotiabank upped their price objective on Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Wednesday. Barclays raised their price target on Ventas from $99.00 to $102.00 and gave the stock an “equal weight” rating in a research report on Monday, August 31st. Royal Bank Of Canada raised their target price on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Jefferies Financial Group upped their target price on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Finally, Cantor Fitzgerald raised their price target on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus target price of $99.00.

View Our Latest Research Report on VTR

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Further Reading

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.